Thursday, 12 December 2019

Pharma News

  • GSK China scandal: New exposé, more murk

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 30 Jun, 2014

    Singapore: In what has been dubbed as the biggest corruption scandal to implicate a foreign company in China, the GlaxoSmithKline case has now come out in the open again. The company is sa...Read more

  • Mylan gets FDA nod for Thiamine Hydrochloride Injection

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 02 Jul, 2012

    Singapore: Mylan Institutional business has received final approval from the US Food and Drug Administration (FDA) for Mylan's abbreviated new drug application (ANDA) for preservative-free...Read more

  • Otsuka, Lundbeck files NDA for schizophrenia drug

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 15 Jul, 2014

    Singapore: Japanese firm Otsuka Pharmaceutical and global firm H Lundbeck have submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for brexpiprazo...Read more

  • Sanofi, Bristol-Myers Squibb to restructuring alliance agreement

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: Sanofi and Bristol-Myers Squibb Company have restructured their long-term alliance following the loss of exclusivity of Plavix and Avapro/Avalide in many major markets. Under th...Read more

  • Taiho seeks Japanese nod for oral cancer agent

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 28 Feb, 2013

    Singapore: Taiho Pharmaceutical submitted an application for approval of the manufacture and marketing of the novel oral nucleoside antitumor agent TAS-102 (combination of trifluorothymidin...Read more

  • FDA approves Boehringer's lung cancer drug Gilotrif

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 15 Jul, 2013

    Singapore: US FDA has approved Boehringer Ingelheim' Gilotrif (afatinib) tablets for oral use, as a new first-line (initial) treatment for patients with metastatic non-small cell lung cance...Read more

  • Big pharma to drive R&D innovation with $4.4 bn

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 11 Jul, 2013

    Singapore: The European Commission (EC) and other leading pharma giants have come together to invest $4.4 billion into programs that would be focused on innovation in the health sector over...Read more

  • Cadila chairman Indravadan Modi passes away

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 27 Nov, 2012

    Bangalore: Veteran industrialist and one of pioneers of Indian pharmaceuticals industry Mr Indravadan Modi, the chairman of Cadila Pharmaceuticals and group companies, passed away on Novemb...Read more

  • NIH study: Diabetes drug Metformin extends life

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 31 Jul, 2013

    Singapore: Long-term treatment with the type 2 diabetes drug metformin improves health and longevity of male mice when started at middle age, reports an international team of scientists led...Read more

  • Bayer Russia to hire 800 staff, increase sales to $1.73 bn

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 11 Sep, 2013

    Singapore: Bayer is going to expand its operations in Russia by adding more than 800 staff over the next four years to fuel sales in the country. The firm expects sales of its products in R...Read more

  • Multiple organzations join hands to curb fake drug business

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: US Pharmacopeial Convention (USP) is gearing up its efforts to combat fake medicine circulating in the market and has joined hands with 11 new organizations to strengthen its glo...Read more

  • FDA approves Eisai's Fycompa

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: Eisai announced that its U.S. subsidiary has received approval from the U.S. Food and Drug Administration (FDA) for the AMPA receptor antagonist Fycompa® (perampanel) as an adj...Read more

  • First-of-its-kind osteoarthritis study done in India

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 21 Sep, 2012

    Bangalore: Signaling relief to over 15 million knee-osteoarthritis patients in India, the world's first study "Osteoarthritis Synvisc One Indian Post Marketing Study" (OASIS) has revealed ...Read more

  • Novartis liver cancer trial with Afinitor flops

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 09 Aug, 2013

    Singapore: Novartis highlighted that the results of a global phase III study showed that Afinitor (everolimus) did not extend overall survival as compared to placebo in patients with locall...Read more

  • Oramed submits pre-IND for exenatide to FDA

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 02 Aug, 2013

    Singapore: Oramed Pharmaceuticals, a developer of oral drug delivery systems, submitted a pre-Investigational New Drug (pre-IND) meeting request to the US FDA for a US-based trial on its or...Read more

  • Alexion to acquire Synageva biopharma for $8.4 bn deal

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 07 May, 2015

    Singapore: Alexion pharmaceuticals recently announced the acquisition of Synageva Biopharma for $8.4 billion. US-based Synageva is a biopharmaceutical company dedicated to discovering, deve...Read more

  • Director resigns at China Nepstar Chain Drugstore

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: Mr. Gary Siu Kwan Sik has resigned as an independent director of China Nepstar Chain Drugstore, the largest drugstore chain in China based on the number of directly operated stor...Read more

  • DKSH expands in Hong Kong

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 12 Nov, 2012

    Singapore: DKSH Business Unit Healthcare, a leading partner for healthcare companies seeking to grow their business in Asia, has signed an agreement with Nong's, traditonal chinese medicine...Read more



Survey Box

Is APAC region emerging as a leader in assistive technologies?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls